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Naturally occurring hypoadrenocorticism is a relatively rare endocrine disorder in the dog. 
The vast majority of cases suffers from primary hypoadrenocorticism which is also known 
as Addison’s disease (AD). It is currently assumed that the major cause is autoimmune 
destruction of the adrenal glands, other causes are bleeding, infarct, infiltrative destruction 
due to abscesses, neoplasia or granulomatous disease. At least 90% of adrenocortical 
tissue has to be destroyed before clinical signs become apparent. In immune mediated AD 
tissue loss usually takes place in a slow and progressive manner over weeks to months. 
Typically, the destruction terminates in absolute deficiencies of glucocorticoids and 
mineralocorticoids with high levels of endogenous ACTH due to negative feedback.  
The disease may occur at any age, most often young-middle aged dogs are affected. 
There is a female predisposition and there is also a genetic predisposition in some breeds 
(e.g. Bearded Collie, Standard poodle, Portugiese water dog, Nova Scotia Duck Tolling 
Retriever). The presentation may be an emergency because of sudden onset of serious 
problems (so called Addison crisis) such as anorexia, lethargy, weakness, collapse, 
dehydration, hypotension and bradycardia (absolute or relative). In those dogs the initial 
symptoms may have been mild and not taken seriously by the owner. Alternatively, the 
dog may be presented due to chronic illness with symptoms such as intermittent lethargy, 
weight loss, weakness, pu/pd, vomiting.  
20 to 30% of dogs with AD reveal a mild to moderate normochromic, normocytic anemia. A 
hematocrit < 20% may be seen in dogs with severe gastrointestinal hemorrhage. Usually, 
patients do not have a stress leucogramm, eosinophilia and/or lymphocytosis is present in 
10-20%. The typical or “classical” laboratory abnormalities are hyperkalemia and/or 
hyponatremia; hyperkalemia occurs in about 90% and hyponatremia in about 80% of  
cases. Severity of the electrolyte alterations range from subtle to very severe and life-
threatening. It should be remembered that although hyponatremia and hyperkalemia are 
often seen in dogs with AD they are not specific for the disease. In about 10% of dogs with 
AD sodium and potassium concentrations are within the normal range, which has been 
referred to as atypical AD. In those dogs diagnosis may be delayed because the typical 
alterations are lacking and therefore the index of suspicion is low. Various authors have 
postulated that in those dogs the destructive (e.g. immune-mediated) process is confined 
to the zones fasciculata/reticularis leading to an isolated glucocorticoid deficiency with 
intact aldosterone secretion (1-3). However, so far there are no histological studies 
confirming that the zona glomerulosa is intact and in most studies aldosterone was not 
measured. We recently investigated cortisol and aldosterone concentrations pre and post 
ACTH (i.e. during an ACTH stimulation test) in healthy dogs, dogs with diseases mimicking 
AD and in dogs with AD. Healthy dogs and dogs with mimicking diseases showed a 
significant increase in cortisol and aldosterone post ACTH, which was lacking in dogs with 
AD. Interestingly, 67 of the 70 dogs with AD had low-undetectable aldosterone 
concentrations independent of the degree of electrolyte abnormalities. In 5 of the 67 dogs 
the so-called atypical AD was present, i.e. the electrolytes were normal (without 
aldosterone!). According to our results it seems likely that also in “atypical” AD the zona 
glomerulosa is destroyed and that in those dogs other mechanisms (most likely of renal 
origin) are able to maintain normal electrolytes. Azotemia is common in dogs with AD and 
is attributable to hypovolemia and hypotension due to decreased renal perfusion and GFR. 
Normally the determination of urine specific gravity is used to differentiate between 
prerenal and renal azotemia; in prerenal azotemia it is greater than 1.030. Although dogs 
with AD have prerenal azotemia, more than 2/3 of these dogs have a urine specific gravity 
of less than 1.030. Therefore, these cases initially cannot be differentiated from those with 
primary renal insufficiency. In about 50% of dogs hypoalbuminemia is present, which is 
associated with gastrointestinal loss and may be severe, 30% demonstrate hypercalcemia 
and 20% hypoglycemia.  
The ACTH stimulation test is the test of choice to confirm AD. Additional measurement of 
cACTH enables differentiation between AD and secondary hypoadrenocorticism, which is 
of particular importance in dogs with normal sodium and potassium concentrations. 
Emergency treatment requires fluid therapy with 0.9% NaCl, moderate to severe 
hyperkalemia may be treated by IV glucose (1-2ml/kg of the 50% glucose solution, dilute if 
application is through peripheral vein). After finishing the ACTH test IV glucocorticoids 
should be given (e.g. methylprednisolone sodium succinat, 2-5 mg/kg). Usually, 
stabilisation of the patient is possible with fluid therapy and glucocorticoid application 
within several hours and 1-2 days, however intensive monitoring is extremely important. 
Thereafter long term therapy should be initiated with mineralocorticoids and 
glucocorticoids (mineralocorticoids: fludrocortisone acetate orally daily or 
desoxycorticosterone pivalate SC every 3 – 4 weeks). Dogs with normal sodium and 
potassium concentrations do not need mineralocorticoid replacement. However, since they 
usually have low aldosterone concentrations and may develop electrolyte changes later in 
the course of the disease close supervision is needed.  
During the first 3 months we re-evaluate dogs every 1 – 3 weeks, thereafter twice per year. 
The prognosis is good.   
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